NUWE · Nuwellis, Inc.
$1.31
+0.01 (+0.77%)
At close · Aug 14
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions, including continued operating losses, negative cash flows from operations, an accumulated deficit of $325.7 million, and the need for additional capital to fund ongoing operations and growth initiatives (including the integration of Rendiatech Ltd., and Israeli company (“Rendiatech”) following the Company’s acquisition), raise substantial doubt about the Company’s ability to continue as a going concern for at least twelve months from the date these financial statements are issued. While management’s plans, including recent financing activities, cost discipline initiatives, and contingency measures, are intended to address these conditions, such plans do not alleviate the substantial doubt.”View the 10-Q filed Aug 13, 2026
Market Cap
$4.78M
Shares
3.65M
Nuwellis, Inc. Earnings Call Transcripts
Every quarterly earnings call for Nuwellis, Inc. (NUWE) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲11.4%
$2.06M
−$3.87M
'22 Q3
22-11-08
▲42.4%
$2.34M
−$1.90M
'22 Q4
23-01-09
▼5.2%
$1.83M
−$6.49M
'23 Q1
23-05-09
▼6.2%
$2.08M
−$4.84M
'23 Q2
23-08-08
▲16.8%
$2.41M
−$3.37M
'23 Q3
23-11-07
▲9.1%
$2.55M
−$5.51M
'23 Q4
24-03-06
▲1.7%
$1.86M
−$4.33M
'24 Q1
24-05-07
▲5.7%
$2.19M
−$7.72M
'24 Q2
24-08-13
▼1.9%
$2.37M
$2.36M
'24 Q3
24-11-12
▼9%
$2.32M
−$1.47M
'24 Q4
25-03-11
▲2.5%
$1.90M
−$3.01M
'25 Q1
25-05-13
▼21.4%
$1.73M
−$12.55M
'25 Q2
25-08-14
▼6.3%
$2.22M
$468,000
'25 Q3
25-11-12
▲4.4%
$2.42M
−$2.42M
'25 Q4
26-03-10
▲26.2%
$2.40M
−$4.54M
'26 Q1
26-05-12
LATEST
▲14.1%
$1.97M
−$4.83M
'26 Q2
26-08-13
Earnings call
FY26 · Q2
2026-08-13
AUGUST 13, 2026 Webcast: Nuwellis, Inc Second Quarter 2026 Earnings READ MORE
Confident tone
Revenue growth and gross margin
Cardiorenal platform and Clarity Prime
Installed base and console placements
Revenue
$1.97M
▲ 14.1% YoY Diluted EPS
$-26.64
Gross margin
76.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-12
Nuwellis, Inc. Q1 FY2026 Earnings Call
Confident tone
RendiaTech acquisition
Pediatrics growth
Financial performance
Revenue
$2.40M
▲ 26.2% YoY Diluted EPS
$-76.65
Gross margin
70.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-10
Nuwellis, Inc. Q4 FY2025 Earnings Call
Positive tone
Rendiatek Acquisition and Critical Care Growth
Gross Margin Expansion
International / EU Exit and Rationalization
Revenue
$2.42M*
▲ 4.4% YoY Gross margin
68.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-12
Nuwellis, Inc. Q3 FY2025 Earnings Call
Positive tone
Aquadex adoption and commercial momentum
Critical care
Heart failure and hospital-based outpatient therapy
Revenue
$2.22M
▼ 6.3% YoY Diluted EPS
$19.60
▼ 99.2% YoY Gross margin
65.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-14
Nuwellis, Inc. Q2 FY2025 Earnings Call
Positive tone
Outpatient heart failure
Cardiac surgery / critical care
Pediatrics growth
Revenue
$1.73M
▼ 21.4% YoY Diluted EPS
$-2134.19
Gross margin
55.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-13
Nuwellis, Inc. Q1 FY2025 Earnings Call
Positive tone
Pediatric Growth
Heart Failure Category
Critical Care Decline
Revenue
$1.90M
▲ 2.5% YoY Diluted EPS
$-1012.55
Gross margin
56.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-11
Nuwellis, Inc. Q4 FY2024 Earnings Call
Revenue
$2.32M*
▼ 9% YoY Gross margin
58.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Nuwellis, Inc. Q3 FY2024 Earnings Call
Positive tone
Clinical Evidence and Publications
Pediatric Growth
CMS Reimbursement Increase
Revenue
$2.37M
▼ 1.9% YoY Diluted EPS
$2563.05
Gross margin
70.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-13
Nuwellis, Inc. Q2 FY2024 Earnings Call
Positive tone
Pediatric business softness
Revenue growth in heart failure and critical care
DaVita pilot slower than expected
Revenue
$2.19M
▲ 5.7% YoY Diluted EPS
$-27713.70
Gross margin
67.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Nuwellis, Inc. Q1 FY2024 Earnings Call
Positive tone
Pediatric growth and QUELimmune launch
Consumable utilization trends
Liquidity and financing
Revenue
$1.86M
▲ 1.7% YoY Diluted EPS
$-35441.70
Gross margin
64.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-06
Nuwellis, Inc. Q4 FY2023 Earnings Call
Positive tone
Heart Failure and Clinical Evidence
Pediatric Business Growth
Revenue and Financial Results
Revenue
$2.55M*
▲ 9.1% YoY Gross margin
54.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Nuwellis, Inc. Q3 FY2023 Earnings Call
Revenue
$2.41M
▲ 16.8% YoY Diluted EPS
$-93006.90
Gross margin
57.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Nuwellis, Inc. Q2 FY2023 Earnings Call
Revenue
$2.08M
▼ 6.2% YoY Diluted EPS
$-187645.50
Gross margin
55.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Nuwellis, Inc. Q1 FY2023 Earnings Call
Revenue
$1.83M
▼ 5.2% YoY Diluted EPS
$-296352.00
Gross margin
58.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-09
Nuwellis, Inc. Q4 FY2022 Earnings Call
Revenue
$2.34M*
▲ 42.4% YoY Gross margin
56.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Nuwellis, Inc. Q3 FY2022 Earnings Call
Revenue
$2.06M
▲ 11.4% YoY Diluted EPS
$-1889244.00
Gross margin
61.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
Nuwellis, Inc. Q2 FY2022 Earnings Call
Revenue
$2.21M
▼ 11.8% YoY Diluted EPS
$-2092471.50
Gross margin
48.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Nuwellis, Inc. Q1 FY2022 Earnings Call
Revenue
$1.93M
▲ 0.4% YoY Diluted EPS
$-2184052.50
Gross margin
57.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-01
Nuwellis, Inc. Q4 FY2021 Earnings Call
Revenue
$1.64M*
▼ 19.7% YoY Gross margin
54.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-09
Nuwellis, Inc. Q3 FY2021 Earnings Call
Revenue
$1.85M
▼ 2.7% YoY Diluted EPS
$-3858750.00
Gross margin
60.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-10
Nuwellis, Inc. Q2 FY2021 Earnings Call
Revenue
$2.51M
▲ 34.6% YoY Diluted EPS
$-3704400.00
Gross margin
60.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-11
Nuwellis, Inc. Q1 FY2021 Earnings Call
Revenue
$1.92M
▲ 17.7% YoY Diluted EPS
$-8334900.00
Gross margin
50.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-03
Nuwellis, Inc. Q4 FY2020 Earnings Call
Revenue
$2.04M*
▲ 49.5% YoY Gross margin
56.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-10
Nuwellis, Inc. Q3 FY2020 Earnings Call
Revenue
$1.90M
▲ 52.1% YoY Diluted EPS
$-10701600.00
Gross margin
46.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-04
Nuwellis, Inc. Q2 FY2020 Earnings Call
Revenue
$1.86M
▲ 11.1% YoY Diluted EPS
$-15949500.00
Gross margin
64.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-12
Nuwellis, Inc. Q1 FY2020 Earnings Call
Revenue
$1.63M
▲ 34.2% YoY Diluted EPS
$-59373300.00
Gross margin
51.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-03
Nuwellis, Inc. Q4 FY2019 Earnings Call
Revenue
$1.37M*
▼ 8.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 earnings calls